These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6653617)

  • 1. Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.
    Brogard JM; Comte F; Lavillaureix J
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):251-9. PubMed ID: 6653617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single- and multiple-dose pharmacokinetics of pipemidic acid in normal human volunteers.
    Klinge E; Männistö PT; Mäntylä R; Mattila J; Hänninen U
    Antimicrob Agents Chemother; 1984 Jul; 26(1):69-73. PubMed ID: 6476816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nalidixic acid, pipemidic acid and cinoxacin on chondrocyte metabolism in explants of articular cartilage.
    Brand HS; van Kampen GP; van der Korst JK
    Clin Exp Rheumatol; 1990; 8(4):393-5. PubMed ID: 2397627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the pharmacokinetics of pipemidic acid in renal insufficiency (author's transl)].
    Brühl P; Köhler T; Gundlach G; Krasemann C
    Arzneimittelforschung; 1981; 31(10):1766-70. PubMed ID: 7198452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.
    Maigaard S; Frimodt-Möller N; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1979 Sep; 16(3):411-6. PubMed ID: 507797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of cinoxacin, cotrimoxazole and pipemidic acid in recurrent infections of the lower urinary tract in long-term therapy].
    Aimè G; Governa M; Polledro P
    Minerva Urol Nefrol; 1987; 39(2):129-34. PubMed ID: 3498226
    [No Abstract]   [Full Text] [Related]  

  • 7. Cinoxacin in urinary tract infections. Theoretical and practical considerations.
    Madsen PO; Frimodt-Møller N; Maigaard S; Nielsen OS; Rodriguez N; Welling PG
    Urology; 1981 May; 17(5):496-9. PubMed ID: 7233671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of pipemidic acid in healthy middle-aged volunteers and elderly patients with renal insufficiency.
    Männistö P; Solkinen A; Mäntylä R; Gordin A; Salo H; Hänninen U; Niinistö L
    Xenobiotica; 1984 Apr; 14(4):339-47. PubMed ID: 6464503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein binding of quinolonecarboxylic acids. I. Cinoxacin, nalidixic acid and pipemidic acid.
    Izumi T; Kitagawa T
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):742-5. PubMed ID: 2752487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Utilisation of pipemidic acid as antibiotic in patients with renal failure insufficiency. Kinetics of serum and urinary concentrations (author's transl)].
    Meyrier A; Kourilsky O; Montay G; Le Verge R
    Pathol Biol (Paris); 1979 Mar; 27(3):181-8. PubMed ID: 382059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cinoxacin in normal volunteers and patients with impaired renal function.
    Ohkawa M; Sugata T; Sawaki M; Okasho A; Kuroda K; Yamada H
    J Antimicrob Chemother; 1981 Dec; 8(6):447-51. PubMed ID: 7333988
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of cinoxacin in humans.
    Black HR; Israel KS; Wolen RL; Brier GL; Obermeyer BD; Ziege EA; Wolny JD
    Antimicrob Agents Chemother; 1979 Feb; 15(2):165-70. PubMed ID: 426511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding of quinolonecarboxylic acids. II. Spectral changes on the interaction of cinoxacin, nalidixic acid and pipemidic acid with human and rat albumins.
    Izumi T; Nagayama T; Kitagawa T
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):746-52. PubMed ID: 2752488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of probenecid on serum levels and urinary excretion of cinoxacin.
    Rodriguez N; Madsen PO; Welling PG
    Antimicrob Agents Chemother; 1979 Mar; 15(3):465-9. PubMed ID: 464575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pipemidic acid in chickens after single intravenous and oral dosings.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Vélez C; Bringas P
    Am J Vet Res; 1990 Nov; 51(11):1756-9. PubMed ID: 2240801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of cinoxacin in elderly patients following repeated oral administration.
    Braga PC; Fraschini F; Scaglione F; Scarpazza G; Schiavi M; Ventura P
    Chemotherapy; 1987; 33(5):309-15. PubMed ID: 3665628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concentration of the pipemidic acid in renal tissue after oral administration].
    Mattina R; Salvia G; Castiglione B; Salvia G; Nicolosi D
    Minerva Urol Nefrol; 1985; 37(3):353-6. PubMed ID: 4089732
    [No Abstract]   [Full Text] [Related]  

  • 20. Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.
    Scavone JM; Gleckman RA; Fraser DG
    Pharmacotherapy; 1982; 2(5):266-72. PubMed ID: 6763208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.